5/13/2018 Janet Wrathall Research

1/7

AbstractMy background prior to training to be a Naturopathwas in education as a Secondary school teacher forten years. After leaving the profession with chronicfatigue syndrome/ME Iset up my own private tutorbusiness and taught pupils with a wide range ofneeds, from Grammar school prep to serious learningdifficulties which included dyslexia, dyspraxia andAutistic spectrum learning disabilities. I still have anumber of pupils on my books.As soon as I became more aware of health issuesfrom the naturopathic standpoint Istarted makingconnections between heavy metal poisoning fromvaccinations and amalgam in the teeth and somesevere pathologies. I myself at that time had justbeen diagnosed with breast cancer and inferti lityand Iwas heavily researching both areas to exhumethe cause of my problems. Having had 17amalgamfillings removed carefully by a dental colleagueDr John Roberts (who isinfamous in leading the wayin holistic dental treatments and founder of the BritishChapter of the International Academy of OralMedicine and Toxicology (IAOMT) a scientificorganisation dealing with the mercury issueandother aspects of biologically safe dentistry with hisfriend and colleague from Harley Street,Dr A C Newbury), I realised that I had been a statisticof the over -zealous use of amalgam in the 70'sand 80's!Further research during my naturopathic training ledme to study for three years under the tutelage ofDrSavely Yurkovsky,a New Yorkcardiologist,international teacher and expert in Bio-energeticmedicine. He has developed hisown system oftesting and relieving the body of heavy metals andwritten many revolutionary papers, explaining theconnection between mercury and lead poisoning inparticular and serious pathologies.From thereon I practised with hissystem of FieldControl Therapy which is

"...based on the novel medical system ofGuided Digital Medicine which operatesdiagnostically and therapeutically on the mostfundamental level of Man's body - energy!"(Savely Yurkovsky MD 2003)

At that point I used my five years of naturopathic,Iridology and medical herbalist training alongside theFCT(Field Control Therapy) which proved to be ofgreat benefit to patients and Istarted to understandthe great relevance of treating serious disease at anenergetic level as well as a biochemical level.The treatment protocols using the FCTsystem,although very effective have to be done under strictE M F free controls l.e. no exposure to electrical andmicrowave emitting devices and circuits like TV,motor vehicles, mobile phones and computers forthree days every month plus keeping to a very strictanti candida diet. Thiswas too restrictive for somepatients and so I turned to the NESProvision systemwhich doesn't have such strict environmentalrestrictions.Currently I use both systems alongside each otherwhich seems to work extremely effectively.

NESHealth Ltd, EastHouse, Braeside BusinessPark, Sterte Avenue West, Poole, Dorset, UK, BH152BX.Tel: +44 (0) 1202785888 Email: research@neshealth.com

mailto:research@neshealth.commailto:research@neshealth.com

5/13/2018 Janet Wrathall Research

2/7

A im of th is S tudyToevaluate the efficacy of the NESHealthInfoceuticals on behaviour and learning issuesidentified for two juvenile male cases (siblingswithinthe same household) who have both, after officialassessment, been placed on the Autistic spectrum,with particular reference to heavy metal burden inboth participants. For the purposes of the study theolder juvenile, aged 8yrs9months will be referred toas Case A and the younger, aged 7yrs2 months asCase B.Case A presents with Asperger's tendencies as well asdyslexia, and has been classified against the Autisticspectrum. He has had 9 vaccinations within hisfirstyear but none thereafter.Case Bpresents with dyslexia and again has beenclassified within the remit of Autistic spectrum disorder.He has had 22 vaccinations within the first 4 years.

It is the intention of the study therefore to see if therewill be an improvement outcome in terms of learning abilities i.e. spelling and reading,particularly phonic interpretation and Improvement in attention and controlled behaviour.

NBAs the boys are from the same household theyboth share the same "nurture" environment.

The reason I am interested in these cases comes fromboth a professional and personal angle. In myteaching capacity I teach a number of dyslexic anddyspraxic pupils and Ialso have an older brother whoexhibits mild Asperger's tendencies.I am also very interested to assesswhether the levelsof heavy metals or the sensitivities to heavy metals inthe body correlates with the degree of autisticspectrum presentations and with the lessening of theheavy metal burden, alongside the rebalancing ofthe Human Body Field that ultimately the NESsystemisdesigned to deliver; we may see an improvementor even an absence of autistic spectrum behaviour.

Introduction According to allopathic medical reports thereappears to be no explanation for the "mysterious"rise in autism, ADD, LD,ADHD and other relatedmental and emotional ailments that we arecurrently experiencing worldwide. Indeed the National Institute of health (NIH)Conference of the world's leading experts onADHD in 1998 conceded that "Our Knowledgeabout the cause or causes of ADHD remainslargely speculative". A convincing argument however ispresented byDrSavely Yurkovsky in one of his powerful articles:"It isonly logical, therefore, that since anaddition of extra mercury to the childhoodvaccinations in the way of a preservative,Thimerosol, has taken place, the rate ofautism (and other eNS disorders) hasskyrocketed by 800% in recent years"according to a study by The Journal of AmericanPhysicians and surgeons 2003.

An updated study from the same source(published 2006) examined the trend for cases ofautism during the period beginning 1994andending 2002 compared with the period from 2002to June 2005. "The trends for increases anddecreases of cases of autism found in the VAERSnational database were consistent with the trendsfound in the CDDC California database. Mostsignificantly, in each database the increasing anddecreasing trends correlate with the time that theexposure to thimerosol through the immunizationschedule was increased and then decreased afterremoval of mercury containing vaccines" The consistency of the effects observed forthe spectrum of NO's, including autism andspeech disorders, and the agreementbetween the observations from two separatedatabases, support the conclusion that theeffect is real and not a chance observation."

The above authors, Dr Mark Geier and David Geieralso show that the biological plausibility of theirstatistical findings issupported by recent toxologicaland molecular studies that reveal the mechanismby which mercury from vaccines can causedamage to the developing brains of children.

NESHealth Ltd, EastHouse, Braeside BusinessPark, Sterte Avenue West, Poole, Dorset, UK, BH152BX.Tel: +44 (0) 1202785888 Email: research@neshealth.com

mailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.com

5/13/2018 Janet Wrathall Research

3/7

Sym ptom s and expec ted prognos is of Case A and BJuly 2010 School Report (NEStreatment started 22nd May 2010)Case A: Very aggressive incident at school prompting areferral July 2009. Specific learning difficulties, especially readingand number work. Bossyand obsessive tendencies. Demands answers. Over exaggerated response to situations e.g. loudcrying in response to what may seem to others alittle event. Head down and a low level droning noise (asignthat he istrying to calm himself). Difficulty making friends. Not confident at reading and spelling, low scoresagainst chronological age. Overall communication score was in the low range(3rd percentile) Children's CommunicationChecklist (CCC2) Sept 2009. spelling, low scoresagainst chronological age."As Case A moves into Year 41 urge him tofocus more in class and to continue to aim highto achieve his full potential."

Expec ted Pro gn os isThisisthe firstseriesof treatments performed on caseA and Bwith them to date only having completed 4NESprotocols sofar in the study out of a proposed 6.Tomy knowledge no other treatment has beenperformed prior to the NESresearch. Theyare nottaking any allopathic prescriptive medication. Inboth cases Iexpect to see an improvement intheir behaviour, hopefully a significant change inthe level of aggression and anger they both exhibit.

Reading and spelling scores are belowchronological age. Unfortunately no data wascollected prior to the study. Assessmentof readingand spelling on 3rdOct 2010indicating both caseA and Bare stillbehind peer group in terms ofliteracy skills.Expect to see an improvement in thisarea by the end of the study.

An improvement insocial skillsand interaction withother children and adults.

Case B: Aggressive behaviour both verbally andphysically towards other children and school staff. Shows frustration in temper tantrums at times e.g.turn taking between him and hisbrother. Expressing needs verbally isan issue and easilyfrustrated causing him to shout out in class. Retreats to a corner of the classroom or hidesunder furniture. Over exaggerated responses. Scores on the low side for both informationprocessing and grammar. The Renfrew ActionPicture Test9.04.09 Speech and Language TherapyDepartment. Not confident at reading and spelling, low scoresagainst chronological age."Case B works well when he isaware of theroutines but can still become unsettled whenroutines change or he isasked to do somethingthat he doesn't want to do. Hisbehaviour onthese occasions can stillbe problematic."

MethodologiesBothcases were scanned once every four weeksusing the NESProvisionsystemand they have bothcompleted 4 out of the 6 treatments and have oneremaining scan to complete and two more fullprotocols.Inorder to document the results,detailed case noteshave been taken each month and both theparticipants and the mother have given an accountof progress.Bothcaseswere asked if theyexperienced any of the following symptoms as aresultof taking the Infoceuticals:

Pain Nausea Tiredness/fatigue Emotional issue... heightened more than usual Head aches Runny Nose

NESHealth Ltd, EastHouse,BraesideBusinessPark,SterteAvenue West, Poole, Dorset,UK, BH152BX.Tel: +44 (0) 1202785888 Email: research@neshealth.com

mailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.com

5/13/2018 Janet Wrathall Research

4/7

ResultsInterviews with the mother of the cases in question elicited a positive response so far to the testing and treatmentsusing the NESsystem.

Case APositiv e Resu lts : No longer getting physical aggression reports fromschool. Improved a little on exaggerated responses. After one month of treatment case A held hismother's hand when out walking and appearedmore settled. Never seen to do that prior totreatment. Temperament generally improved for the better. Made a new friend at school and seems to beimproving with social skills.

Test 1e;--

T est 2

T est 3

Still issues wi th : Only over last treatment period: more hyperactivethan usual. Quite alot of anger being elicited ...feels like he isopening up a pressure valve! Stillcontinues with droning noises Complained of alot of stomach aches over lasttreatment.

T est 4

T est 5j) N ES H EA LT H Pr.

5/13/2018 Janet Wrathall Research

5/7

Case BPositiv e Resu lts : No longer hides under the table at school. Swimming was a major issueand held on to a lotof fear! Now he no longer has a problem withswimming and actually looksforward to going!

Co-ordination isa great deal better, very good athand eye co-ordination sports.

Smilesmuch more and seems much more contentin hisskin!

Much improvement with reading skillsover the lasttwo months. Mother says"something has clicked"in terms of letter recognition and phonicunderstanding of words.

Test 1

T es t 2

'-~.------ ..------.--._----_.. . _ - ..------. . . . _-----._------~-___ o _--_ _ ..-- _ . ---. . - . - - -

T es t 3

Still issues wi th : Feeling the underdog with hisolder brother andgetting into arguments.

Hyperactive

T es t 4

T es t 5_ j ) N E S H E A LT H-- _ ,_ 1-1-1"_ 1-= MiL"--- !IlL1""-"''-I'''~- ::11'''"-- . . . _ IIooL1'''''--- -= II!!![

I"'"'~'- I- I-I""~-I""-'~' -''''-- II!!L 1-= !!!!.:I"'"~'"~' 1- !IlL I!IIL 1- !IlLI""~'-I""-'~G1"""-""- IIoL IoL1""'-"- III[ -=1"""_"_I""-~-I[ I- I-Comparison Data

NESHealth Ltd, East House, Braeside Business Park, Sterte Avenue West, Poole, Dorset, UK, BH15 2BX.Tel: +44 (0) 1202785888 Email: research@neshealth.com

mailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.com

5/13/2018 Janet Wrathall Research

6/7

Conclus ionThe most significant findings from the study werethose of the juvenile male siblings, both within theremit of the autistic spectrum and includingAsperger's tendencies aswell as dyslexia.Initial ly Iwas interested in how the presence of heavymetals from vaccinations (in the form of thimerosal)had potentially impacted upon their health status.The NESreadings implicated that there was an issuewith heavy metal presence and tolerance generallyand as the scan progressed thisinterestinglyrevealed itself in waves as if the body could onlydeal with excreting a small amount at a time frombones and circulatory aspects. Thisisin line with thefindings of Professor Frazerwhen he says "the boneswill only allow a certain amount of toxins l.e. heavymetals to be released a little at a time", presumablythat is the innate intelligence of the Body Field atwork. If too much was released all at once then thebody would not be able to cope and vital systemswould shut down.NESmaintains that"The presence of heavy metals in the bodycan have a significantly detrimental effect oncellular functions, energetic process and thebody field as a whole. Bio-sodium isa super-conductive version of sodium and appears tobe vital for the transfer of holographicinformation patterns in the body matrix. Thepresence of heavy metals and excess sodiumfrom table salt appears to disturb the bio-sodium balance and thus degrade informationtransfer."ED16Bone Driver and ES15 Heavy metal/Bio-sodiumdetox over a 16month period: Case A appears to have had a high degree ofmetal involvement in his picture, particularly in thelast third time frame of the treatment at both EDand ESlevels. Case Bon the other hand appears to have muchlessof an issuewith the heavy metals as scansummary shows ED 16to have no red bars in thelast third time frame. Also ES15issignificantly better.

Overall Case Bhas improved significantly morethan Case A with reading, writing and spellingcomponents. As NESresearch suggests, if heavymetal issuesappear to be a high priority area toclear then adjunct preparations may have to beadded to the NESprotocol.Noteworthy is the fact that ET7came up on 6occasions during scanning of the siblings. Thisistheterrain tissue related to chronic fatigue: encephalon,pituitary, thyroid, pancreas, small intestine, liver, CNS,

eyes, bladder and kidneys. It isperhaps pertinent topoint out that heavy metals migrate to these vitalorgans and of course that affects the level ofimmunity in the individual and therefore prepares theway for pathogens to take hold and even morph intoan energetic resonance as NEStheory maintains.

The next areas to present frequently in the scans wereas follows and came up on 5 occasions: ED1Source Master Energy driver. EI7 Blood/gallbladder: motor cortex, Grey matter,Eye contact, Decisiveness, Will power, honesty andloyalty. EI8 Microbes in the liver: vision, iris,retina, opticcortex, verbosity, calmness, elation and tolerance. ES5 Auto immune: addresses incorrect productionof antibodies. BSHologram: Integration of brainstem, Heart andMatrix. Emotional conflictAgain, a significant finding here is the fact that manyvision and emotional issuesrelated to the autisticspectrum are to be seen in the above sectors. Theauto immunity component again could possibly berelated to the degree of damage by heavy metals?

The following were seen on an average of 4occasions over the screening period: ED9Muscle: where we hold onto old emotions! EI11Heavy metals in stomach: stomach,duodenum, oesophagus, HCL& pepsin, maxillarysinus, bone marrow (blood cell production), frontallobes, testes, testosterone, groin, heavy metals,environmental toxins. ET2Immunity: red and yellow bone marrow. Blood,frontal lobe and chronic infections. ET3Immunity: red and yellow bone marrow, spleen,frontal lobes. Lossof viral immunity. ET4 Nerves: Brain, central and peripheral nervoussystems,arteries and blood. Fuzzyhead! ET5BSV:Skin, lungs, larynx, neural ganglia, motorcortex. Benign growth.Again it is interesting to see that heavy metals showup here and also the haematopoietic zone ie thered and yellow bone marrow where alot of heavymetals are stored by the body. Also frontal lobe andreferences to fuzzy head appear to be relevantwhen analysing the autistic presentation.

NESHealth Ltd, EastHouse, Braeside BusinessPark, Sterte Avenue West, Poole, Dorset, UK, BH152BX.Tel: +44 (0) 1202785888 Email: research@neshealth.com

mailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.com

5/13/2018 Janet Wrathall Research

7/7

Discussion of In foceu tico ls given on pro toco lsCase A CaseBThe very first treatment protocol involved: The first protocol adopted used the followingInfoceuticals: ED8Stomach and heavy metal detox ED2 Imprinter ED16Bone, heavy metal detox ED13Immunity ET6Poor chest immunity ET7CFSEncephalon, pituitary etc ...Clearly there appears to be some heavy metal issuehere and it was revealed on first testing. LiberatorInfoceutical was used quite frequently in protocolswhich cause extreme behaviour on some occasions.ESRwas then required to be used on the wrist in orderto calm down the participant. The mother reportedthat she found the ESRInfoceutical to be prettyeffective in calming and soothing a reactionary child.

Any sign of heavy metal issueswere not revealed untilthe 4th testing. Case Bhad received 22 vaccinationsin hisfirst 4 years of life, a considerable amount lessthan his older sibling. Perhaps the amount depositedin the bones had moved to a very deep level and asthe first scan suggests other systems of the body,particularly the main organs like the endocrine glandsneeded corrective procedures before the metalrelease could begin!

The mother decided she was so pleased with the resultsof treatment after the original 6 month research periodthat she wanted to continue with treatment for several more months and isindeed stillwil ling to continuetreatment at present. Extra adjunct heavy metal clearance therapy has been applied to their protocol and theywill resume NESprotocol in a couple of month's time. A two month period off the NESprotocol was agreed uponas we tackle the heavy metal issue.Of course it isn't all about heavy metals and the discussion to date has mentioned the high incidence ofemotional factors and "brain" correction drops in the protocols allowing for free communication of informationwithin the Body Field.

Personally I have been extremely pleased with the outcome of the research. It isa very small sample but hasrevealed some interesting results. Isuppose the most important comments come from the participants themselvesor the parents of some of the younger participants. The siblings have progressed significantly over the period ofstudy which isvery encouraging for further work in thisarea.

NESHeolth Ltd, EastHouse, Braeside BusinessPark, Sterte Avenue West, Poole, Dorset, UK, BH152BX.Tel: +44 (0) 1202785888 Email: research@neshealth.com

mailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.commailto:research@neshealth.com